Influence of the sulfonylurea drug glibenclamide on the OATP1B1-and OATP1B3-mediated uptake

被引:0
|
作者
Klatt, S. [1 ]
Fromm, M. F. [1 ]
Koenig, J. [1 ]
机构
[1] Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, Erlangen, Germany
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:79 / 79
页数:1
相关论文
共 50 条
  • [1] OATP1B1-and OATP1B3-mediated Pravastatin Uptake: Determination of Uptake Kinetics and Influence of Coadministered Drugs
    Kindla, J.
    Seithel, A.
    Bachmakov, I
    Fromm, M. F.
    Koenig, J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 97 - 97
  • [2] Differential Preincubation Effects of Nicardipine on OATP1B1-and OATP1B3-Mediated Transport in the Presence and Absence of Protein: Implications in Assessing OATP1B1-and OATP1B3-Mediated Drug-Drug Interactions
    Kayesh, Ruhul
    Tambe, Vishakha
    Xu, Chao
    Yue, Wei
    PHARMACEUTICS, 2023, 15 (03)
  • [3] Long-lasting Inhibitory Effects of Cyclosporin A, but Not Tacrolimus, on OATP1B1-and OATP1B3-mediated Uptake
    Shitara, Yoshihisa
    Takeuchi, Kumiko
    Nagamatsu, Yoshiko
    Wada, Satomi
    Sugiyama, Yuichi
    Horie, Toshiharu
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (04) : 368 - 378
  • [4] Preclinical Mouse Models To Study Human OATP1B1-and OATP1B3-Mediated Drug-Drug Interactions in Vivo
    Durmus, Selvi
    Lozano-Mena, Gloria
    van Esch, Anita
    Wagenaar, Els
    van Tellingen, Olaf
    Schinkel, Alfred H.
    MOLECULAR PHARMACEUTICS, 2015, 12 (12) : 4259 - 4269
  • [5] ASSESSING THE OATP1B1-AND OATP1B3-MEDIATED DRUG-DRUG INTERACTION POTENTIAL OF MAMMALIAN TARGET OF RAPAMYCIN (MTOR) INHIBITOR EVEROLIMUS
    Farasyn, Taleah
    Alam, Khondoker
    Crowe, Alexandra
    Neuhoff, Sibylle
    Hatley, Oliver
    Wang, Xueying
    Zhang, Pengyue
    Ding, Kai
    Li, Lang
    Yue, Wei
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S48 - S48
  • [6] Effects of Uremic Serum Residue on OATP1B1-and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes
    Uchiyama, Hitoshi
    Tsujimoto, Masayuki
    Kimura, Akari
    Yuki, Eriko
    Saiki, Takashi
    Yoshida, Takuya
    Furukubo, Taku
    Izumi, Satoshi
    Yamakawa, Tomoyuki
    Tachiki, Hidehisa
    Minegaki, Tetsuya
    Nishiguchi, Kohshi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2019, 23 (02) : 126 - 132
  • [7] Effect of repaglinide on OATP1B1- and OATP1B3-mediated transport
    König, J
    Bachmakov, I
    Fromm, MF
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 137 - 137
  • [8] Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1-and OATP1B3-Mediated Transport
    Pahwa, Sonia
    Alam, Khondoker
    Crowe, Alexandra
    Farasyn, Taleah
    Neuhoff, Sibylle
    Hatley, Oliver
    Ding, Kai
    Yue, Wei
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (08) : 2123 - 2135
  • [9] Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1-and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1-and OATP1B3-Mediated Drug-Drug Interactions
    Farasyn, Taleah
    Crowe, Alexandra
    Hatley, Oliver
    Neuhoff, Sibylle
    Alam, Khondoker
    Kanyo, Jean
    Lam, TuKiet T.
    Ding, Kai
    Yue, Wei
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (10) : 3443 - 3456
  • [10] Assessing OATP1B1-and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib Using R-Value and Physiologically-Based Pharmacokinetic Models
    Kayesh, Ruhul
    Farasyn, Taleah
    Crowe, Alexandra
    Liu, Qiang
    Pahwa, Sonia
    Alam, Khondoker
    Neuhoff, Sibylle
    Hatley, Oliver
    Ding, Kai
    Yue, Wei
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (01) : 314 - 324